American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 452-462 , March 2010

A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences

  • Thomas J. Hoerger, PhD

      Affiliations

    • RTI International, Research Triangle Park, NC
    • Corresponding Author InformationAddress correspondence to Thomas J. Hoerger, PhD, RTI International, 3040 Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709
    • ,
  • John S. Wittenborn, BS

      Affiliations

    • RTI International, Research Triangle Park, NC
    • ,
  • Joel E. Segel, BA

      Affiliations

    • RTI International, Research Triangle Park, NC
    • ,
  • Nilka R. Burrows, MPH, MT

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Kumiko Imai, PhD

      Affiliations

    • UNICEF Swaziland, Mbabane, Kingdom of Swaziland, Bethesda, MD
    • ,
  • Paul Eggers, PhD

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
    • ,
  • Meda E. Pavkov, MD, PhD

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Regina Jordan, MPH

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Susan M. Hailpern, DrPH, MS

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Anton C. Schoolwerth, MD, MSHA

      Affiliations

    • Dartmouth Hitchcock Medical Center, Lebanon, NH
    • ,
  • Desmond E. Williams, MD, PhD

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Centers for Disease Control and Prevention CKD Initiative

Received 28 April 2009 ,Accepted 12 November 2009.

References 

  1. Coresh J, Selvin E, Stevens L, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047
  2. Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2009;53:218–228
  3. US Renal Data System. USRDS 2008 Annual Data Report, vol 3. Reference Tables on End-Stage Renal Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;Table B.1, p 31. http://www.usrds.org/2008/ref/B_Prevalence_08.pdf. Accessed July 30, 2009
  4. US Renal Data System. USRDS 2008 Annual Data Report, vol 2: Atlas of End-Stage Renal Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;Fig 11.1, p 177. http://www.usrds.org/2008/pdf/V2_11_2008.pdf. Accessed July 30, 2009
  5. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
  6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  7. Smith DH, Nichols GA, Gullion CM, Johnson ES, Keith D. Predicting costs of care in chronic kidney disease: The role of comorbid conditions. Internet J Nephrol. 2007;4(1):http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijne/vol4n1/cost.xml. Accessed October 31, 2007
  8. US Renal Data System. USRDS 2008 Annual Data Report, vol 1: Atlas of Chronic Kidney Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;Fig 5.2, p 84. http://www.usrds.org/2008/pdf/V1_05_2008.pdf. Accessed July 30, 2009
  9. Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD (2: The cost-effectiveness of microalbuminuria screening). Am J Kidney Dis. 2010;55(3):463–473
  10. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290(23):3101–3114
  11. National Kidney Foundation. Guideline 5: assessment of proteinuria (K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification). Am J Kidney Dis. 2002;39(suppl 1):S93–S102
  12. US Census Bureau. Table 4: Annual estimates of the population by sex and age for the United States: April 1, 2000 to July 1, 2007 (NC-EST2007-04-WANH, NC-EST2007-04-BAC, NC-EST2007-04-Hisp). Washington, DC: Population Division, US Census Bureau; May 1, 2008;
  13. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–232
  14. Mann JF, Gerstein HC, Yi QL, et al. Development of renal disease in people at high cardiovascular risk: result of the HOPE randomized study. J Am Soc Nephrol. 2003;14:641–647
  15. Cowie CC, Rust KF, Bryd-Hold DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263–1268
  16. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in US adults, 1997-2003. Am J Prev Med. 2006;30(5):371–377
  17. Maurice E, Trosclair A, Merritt R. Cigarette smoking among adults—United States, 2004. MMWR Morbid Mortal Wkly Rep. 2005;54(44):1121–1124
  18. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005;46(2):320–327
  19. Cottone S, Nardi E, Mule G, Vadala A. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol. 2007;67(4):209–216
  20. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1990;121:293–298
  21. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54(14):http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_14.pdf. Accessed July 29, 2009
  22. National Center for Health Statistics. Worktable 210R: death rates for 113 selected causes, alcohol-induced causes, drug-induced causes, and injury by firearms by 5-year age groups, race, and sex: United States 2003. http://www.cdc.gov/nchs/data/statab/Mortfinal2003_worktable210r.pdfMarch 2006;Accessed July 30, 2007
  23. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626–634
  24. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990 (The effect of secular trends in risk factors and treatment). JAMA. 1997;277(7):535–542
  25. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the coronary heart disease policy model. Am J Public Health. 1987;77(11):1417–1426
  26. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  27. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  28. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
  29. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (NIH Publication 01-3670). Bethesda, MD: National Institutes of Health; 2001;
  30. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401
  31. US Renal Data System (USRDS). RenDER Renal Data Extraction and Referencing System (ESRD death rate per 1,000 patient years). http://www.usrds.org/odr/xrender_home.aspAccessed June 18, 2007
  32. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation (Report of the ISPOR task force on good research practices—modeling studies). Value Health. 2003;6:9–17
  33. US Renal Data System. USRDS 2006 Annual Data Report: incidence of Reported ESRD Reference Tables. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;Table A.2, p 10. http://www.usrds.org/2006/ref/A_incidence_06.pdf. Accessed July 30, 2009
  34. National Kidney Foundation. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(suppl 2):S12–S154
  35. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? (A comparative survival study of patients over 75 years with chronic kidney disease stage 5). Nephrol Dial Transplant. 2007;22:1955–1962
  36. Navaneethan SD, Nigwekar S, Sengodan M, et al. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored. Nephron Clin Pract. 2007;106:c113–c118
  37. Health Care Financing Administration. Medicare coverage of kidney dialysis and kidney transplant services. http://www.medicare.gov/Publications/Pubs/pdf/11360.pdf2008;Accessed October 31, 2008
  38. Szklo M, Nieto EJ. Section 1.2: analysis of age, birth cohort, and period effects. In: Epidemiology: Beyond the Basics. Gaithersburg, MD: Aspen Publishers; 2000;p. 5–16
  39. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–973

 Originally published online as doi:10.1053/j.ajkd.2009.11.016 on February 1, 2010.

 Information on members of the Centers for Disease Control and Prevention CKD Initiative is available at www.cdc.gov/diabetes/projects/kidney.htm.

PII: S0272-6386(09)01597-2

doi: 10.1053/j.ajkd.2009.11.016

American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 452-462 , March 2010

Article Tools

* Image Usage & Resolution